Brown Advisory’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.9M | Buy |
784,645
+33,247
| +4% | +$870K | 0.03% | 358 |
|
|
2026
Q1 | $21.1M | Sell |
751,398
-21,521
| -3% | -$573K | 0.03% | 317 |
|
|
2025
Q4 | $19.2M | Sell |
772,919
-85,440
| -10% | -$2.15M | 0.03% | 336 |
|
|
2025
Q3 | $21.9M | Buy |
858,359
+3,659
| +0.4% | +$90.3K | 0.03% | 314 |
|
|
2025
Q2 | $20.7M | Sell |
854,700
-82,589
| -9% | -$1.93M | 0.03% | 307 |
|
|
2025
Q1 | $23.8M | Sell |
937,289
-117,326
| -11% | -$3.07M | 0.03% | 294 |
|
|
2024
Q4 | $28M | Sell |
1,054,615
-66,142
| -6% | -$1.79M | 0.04% | 294 |
|
|
2024
Q3 | $32.4M | Sell |
1,120,757
-20,922
| -2% | -$610K | 0.04% | 268 |
|
|
2024
Q2 | $31.9M | Buy |
1,141,679
+69,994
| +7% | +$1.93M | 0.04% | 270 |
|
|
2024
Q1 | $29.7M | Sell |
1,071,685
-6,287
| -0.6% | -$174K | 0.04% | 283 |
|
|
2023
Q4 | $31M | Sell |
1,077,972
-63,145
| -6% | -$1.91M | 0.04% | 265 |
|
|
2023
Q3 | $37.9M | Sell |
1,141,117
-15,956
| -1% | -$564K | 0.06% | 230 |
|
|
2023
Q2 | $42.4M | Sell |
1,157,073
-30,499
| -3% | -$1.19M | 0.07% | 217 |
|
|
2023
Q1 | $48.5M | Sell |
1,187,572
-49,579
| -4% | -$2.14M | 0.08% | 193 |
|
|
2022
Q4 | $63.4M | Sell |
1,237,151
-788
| -0.1% | -$37.8K | 0.12% | 155 |
|
|
2022
Q3 | $54.2M | Buy |
1,237,939
+166,758
| +16% | +$8.1M | 0.11% | 171 |
|
|
2022
Q2 | $56.2M | Buy |
1,071,181
+18,290
| +2% | +$932K | 0.11% | 166 |
|
|
2022
Q1 | $54.5M | Sell |
1,052,891
-84,878
| -7% | -$4.4M | 0.08% | 194 |
|
|
2021
Q4 | $67.2M | Buy |
1,137,769
+82,962
| +8% | +$4.11M | 0.08% | 172 |
|
|
2021
Q3 | $45.4M | Buy |
1,054,807
+8,231
| +0.8% | +$365K | 0.07% | 206 |
|
|
2021
Q2 | $41M | Buy |
1,046,576
+880
| +0.1% | +$34.2K | 0.06% | 223 |
|
|
2021
Q1 | $37.9M | Sell |
1,045,696
-15,118
| -1% | -$537K | 0.06% | 216 |
|
|
2020
Q4 | $39M | Sell |
1,060,814
-48,308
| -4% | -$1.77M | 0.07% | 189 |
|
|
2020
Q3 | $38.6M | Sell |
1,109,122
-42,082
| -4% | -$1.48M | 0.08% | 167 |
|
|
2020
Q2 | $35.7M | Sell |
1,151,204
-5,134
| -0.4% | -$174K | 0.08% | 165 |
|
|
2020
Q1 | $35.8M | Buy |
1,156,338
+5,552
| +0.5% | +$189K | 0.11% | 144 |
|
|
2019
Q4 | $42.8M | Sell |
1,150,786
-19,200
| -2% | -$684K | 0.11% | 156 |
|
|
2019
Q3 | $39.9M | Sell |
1,169,986
-8,166
| -0.7% | -$297K | 0.11% | 159 |
|
|
2019
Q2 | $48.4M | Sell |
1,178,152
-99,036
| -8% | -$3.93M | 0.14% | 142 |
|
|
2019
Q1 | $51.5M | Sell |
1,277,188
-39,679
| -3% | -$1.59M | 0.15% | 136 |
|
|
2018
Q4 | $54.5M | Sell |
1,316,867
-17,524
| -1% | -$727K | 0.18% | 103 |
|
|
2018
Q3 | $55.8M | Sell |
1,334,391
-11,788
| -0.9% | -$454K | 0.16% | 125 |
|
|
2018
Q2 | $46.3M | Buy |
1,346,179
+43,569
| +3% | +$1.49M | 0.14% | 130 |
|
|
2018
Q1 | $43.9M | Sell |
1,302,610
-181,426
| -12% | -$6.24M | 0.14% | 128 |
|
|
2017
Q4 | $51M | Sell |
1,484,036
-7,409
| -0.5% | -$253K | 0.16% | 129 |
|
|
2017
Q3 | $50.5M | Sell |
1,491,445
-64,606
| -4% | -$2.08M | 0.17% | 124 |
|
|
2017
Q2 | $49.6M | Buy |
1,556,051
+109,215
| +8% | +$3.44M | 0.15% | 122 |
|
|
2017
Q1 | $47M | Sell |
1,446,836
-33,730
| -2% | -$1.06M | 0.16% | 124 |
|
|
2016
Q4 | $45.6M | Buy |
1,480,566
+34,295
| +2% | +$1.05M | 0.16% | 124 |
|
|
2016
Q3 | $46.5M | Buy |
1,446,271
+88,286
| +7% | +$2.95M | 0.16% | 112 |
|
|
2016
Q2 | $45.4M | Buy |
1,357,985
+104,142
| +8% | +$3.32M | 0.16% | 108 |
|
|
2016
Q1 | $35.3M | Buy |
1,253,843
+237,178
| +23% | +$6.77M | 0.12% | 124 |
|
|
2015
Q4 | $31.1M | Buy |
1,016,665
+4,786
| +0.5% | +$151K | 0.11% | 143 |
|
|
2015
Q3 | $30.2M | Buy |
1,011,879
+152,582
| +18% | +$4.89M | 0.11% | 139 |
|
|
2015
Q2 | $27.3M | Buy |
859,297
+17,412
| +2% | +$567K | 0.09% | 157 |
|
|
2015
Q1 | $27.8M | Buy |
841,885
+3,774
| +0.5% | +$120K | 0.09% | 160 |
|
|
2014
Q4 | $24.8M | Sell |
838,111
-1,902
| -0.2% | -$54.5K | 0.08% | 170 |
|
|
2014
Q3 | $23.6M | Buy |
840,013
+5,770
| +0.7% | +$162K | 0.08% | 166 |
|
|
2014
Q2 | $23.5M | Sell |
834,243
-104,443
| -11% | -$2.98M | 0.07% | 169 |
|
|
2014
Q1 | $28.6M | Sell |
938,686
-1,535,001
| -62% | -$45.8M | 0.09% | 153 |
|
|
2013
Q4 | $71.9M | Sell |
2,473,687
-14,727
| -0.6% | -$429K | 0.23% | 64 |
|
|
2013
Q3 | $67.8M | Sell |
2,488,414
-63,519
| -2% | -$1.73M | 0.24% | 64 |
|
|
2013
Q2 | $67.8M | Buy |
+2,551,933
| New | +$70.5M | 0.27% | 57 |
|
Other funds holding PFE
Brown Advisory's PFE Position: Q2 2026 in Review
Brown Advisory increased its Pfizer (PFE) stake by 4.4% in Q2 2026, buying an estimated $870K and bringing the position to 784,645 shares worth $18.9M. The position accounts for 0.03% of the portfolio, ranked #358.
Brown Advisory first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $71.9M in Q4 2013. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Brown Advisory held 784,645 shares of Pfizer worth $18.9M as of Q2 2026.
- Brown Advisory bought 33,247 Pfizer shares in Q2 2026, an estimated $870K.
- Pfizer made up 0.03% of Brown Advisory's portfolio in Q2 2026, its #358 holding.
- Brown Advisory first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Brown Advisory's Pfizer position peaked at $71.9M in Q4 2013.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Brown Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.